Reynolds Vuse E-Cigarette Market Share Increases, Juul Ranking 2rd

Business by 2FIRSTS.ai
Nov.20.2023
Reynolds Vuse E-Cigarette Market Share Increases, Juul Ranking 2rd
According to Journalnow, Reynolds Tobacco's Vuse e-cigarette market share increases to 42.1%, surpassing Juul's 24.4%.

According to a recent report by Journalnow, Reynolds Tobacco's e-cigarette brand Vuse has seen a slight increase in market share, rising to 42.1%. This surpasses the second-ranked Juul, which has maintained a market share of 24.4%.

 

Meanwhile, the market share of NJoy, a subsidiary of Altria Group and ranked number three, has not significantly increased, remaining at 2.5%.

 

In addition, Altria and British American Tobacco warn that the prevalence of illegal synthetic nicotine e-cigarettes is increasing in the American market. According to estimates by both companies, these illicit synthetic e-cigarette products represent approximately half of the domestic market share in the United States.

 

According to reports, this report covers a four-week period from the previous report until November 4th. Nielsen's data for this report mostly comes from major retail chains.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Three Refuse Truck Fires in Two Weeks in Glasgow; GMB Calls for Stronger E-Cigarette Battery Recycling and Public Awareness
Three Refuse Truck Fires in Two Weeks in Glasgow; GMB Calls for Stronger E-Cigarette Battery Recycling and Public Awareness
The GMB union says three compartment fires occurred in Glasgow’s newly deployed refuse trucks over the past two weeks, with initial checks pointing to lithium-ion batteries from e-cigarettes being crushed and igniting during compaction.
Sep.23 by 2FIRSTS.ai
InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
At InterTabac 2025, nicotine pouches emerged as one of the biggest highlights. Hall 6 was almost entirely taken over by pouch brands. Based on 2Firsts’ on-site observations, products commonly featured high nicotine strengths starting at 15 mg, with some reaching as high as 150 mg. Beyond nicotine pouches, exhibitors also rolled out caffeine/energy pouches, CBD pouches, and oral dissolvable films, while heavily emphasizing “Made in Sweden” as a market credential. Multiple OEM providers showcased
Sep.20 by 2FIRSTS.ai
Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point
Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point
As regulations tighten, consumer habits evolve, and new nicotine products reshape the market, the cigar industry is undergoing a quiet but profound transformation. In this exclusive interview, 2Firsts speaks with Cigar Sense — a data-driven sensory analysis firm — to explore what’s really changing in cigars, and what it means for manufacturers, retailers, and smokers around the world.
Nov.10
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
In Sept 2025, the US FDA launched a nicotine pouch PMTA pilot to boost review efficiency, streamline processes and uphold strict scientific standards. Based on the "tobacco product health risk continuum" concept, it shortens cycles by focusing on key product factors and enhancing real-time communication with applicants. The FDA also urges child-resistant packaging to tackle kids’ accidental exposure, emphasizes scientific review for new tobacco products, and has approved 20 nicotine pouches so f
Sep.19 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Product | Featuring an ultra-thin metal body and a “Champagne Gold” design, Sikary launches the Sikary Fit in the Middle East
Product | Featuring an ultra-thin metal body and a “Champagne Gold” design, Sikary launches the Sikary Fit in the Middle East
Sikary has listed its new disposable “Fit” on the official site and UAE channels. The device features a 13 mm metal body with a 12 mL e-liquid chamber and is advertised for up to 12,000 puffs, priced at around AED 35 per unit.
Oct.28 by 2FIRSTS.ai